2024 Volume 74 Issue 1 Pages 1-9
Background: Diabetes mellitus (DM) is a global health challenge affecting patient well-being and quality of life (QoL). This study aimed to validate the Mongolian version of the Diabetes Quality of Life Brief Clinical Inventory (MVDQOL-BCI) in patients with type II DM in Mongolia.
Methods: Data were collected from 197 participants across three hospitals in Ulaanbaatar. Reliability was assessed using Cronbach’s alpha and the intraclass correlation coefficient (ICC). Pearson’s correlation was used for criterion-related validity and discriminant validity were examined using demographic, disease-specific, and general QoL questionnaires.
Results: The MVDQOL-BCI demonstrated strong internal consistency (α＝0.853) and satisfactory test-retest reliability (ICC＝0.842). Criterion-related validity was confirmed with the Asian DQOL total score, EQ-visual analog scale score, short-form 36 total scores, 8 subscales, and HbA1c percentage (p<0.05). Discriminant validity revealed better QoL was associated with females, higher education, higher income, shorter diabetes duration, and non-insulin therapy use.
Conclusions: The MVDQOL-BCI is a reliable and valid tool for assessing QoL in adult Mongolian patients with DM. Our findings support the extensive utilization of the MVDQOL-BCI and facilitates a deeper understanding of the impact of diabetes and its management on patient well-being.
